Rooftop raiders steal $76m of Lilly products
March 18, 2010Manufacturing and Production, Sales and Marketing lilly, supply chain, theft
Thieves have made off with $75 million-worth of central nervous system, cardiovascular and cancer drugs from an Eli Lilly distribution …
Roche delivers updated pipeline
March 18, 2010Cancer, Roche
Roche says its pipeline can sustain its growth in oncology and increase its presence in personalised healthcare. Roche also plans …
Publication planning: piecing the jigsaw together
March 18, 2010Medical Communications medical education, publication
In the pharmaceutical industry where every statement of fact must be referenced, trial data is fundamental to the delivery of …
Athena expands account team
March 18, 2010Medical Communications Athena, appointment, medical communications
London-based PR agency Athena has appointed Rhian Mullock as senior account executive.She have more than two and a half years …
WHO suspends use of Sanofi-Aventis vaccine
March 18, 2010Manufacturing and Production Sanofi-Aventis, Shantha Biotechnics, Vaccine
The World Health Organization has temporarily stopped procurement and use of a combination vaccine supplied by Sanofi-Aventis subsidiary Shantha Biotechnics …
Talking Point: Specialist logistics provision
March 18, 2010Manufacturing and Production BioStorage Technologies, Talking Point, logistics, supply chain, talking logistics
“The world is getting smaller” is a quote that is frequently heard in conversations about the economy, business, health care, …
LEC appoints Alison Squire
March 18, 2010Medical Communications LEC, Lane Earl Cox, appointment, medical communications
Lane Earl Cox has appointed Alison Squire as international account director.She joins the advertising agency from HC&B Healthcare and has …
Genzyme plays down Irish contamination
March 18, 2010Manufacturing and Production Cerezyme, Contamination, Fabrazyme, Genzyme
The contamination problems plaguing Genzyme in the US have also appeared in product manufactured at its plant in Waterford, Ireland, …
Tekturna fails to show heart attack benefit
March 17, 2010Research and Development Diovan, Novartis, Tekturna, hypertension
Novartis’ hypertension treatment Tekturna has failed to show it helps patients recover from a heart attack when added to standard …
UK to get biotech academy
March 17, 2010Business Services biotech, pharma training, skills
A national biotech academy will be set up in the UK as part of a government plan to ensure that …
Study boost for atrial fibrillation drugs
March 17, 2010Research and Development Pradaxa, VTE, Xarelto, apixaban, betrixaban
Two rival drugs have both shown benefits over warfarin in patients with atrial fibrillation, according to new research. Boehringer Ingelheim’s …
Shipra Singh joins Porter Novelli
March 17, 2010Medical Communications Porter Novelli, appointment, medical communications
Porter Novelli has appointed Shipra Singh as head of healthcare for Europe, the Middle East and Africa. She was most …
WuXi’s growth slows
March 17, 2010Research and Development CRO, China, WuXi
WuXi Pharmatech, one of China’s leading contract research organisations, has been motoring ahead in recent quarters while its western counterparts …
FDA questions delay long-acting Byetta
March 17, 2010Manufacturing and Production Bydureon, Byetta, Syncria, Victoza
A once-weekly formulation of Eli Lilly and Amylin Pharmaceuticals’ blockbuster diabetes medication Byetta has hit a manufacturing hurdle en route …
Bill Burns joins Shire board
March 17, 2010Research and Development, Sales and Marketing Shire, appointment, research and development, sales and marketing
Former Roche pharma chief executive Bill Burns has joined the board at Shire as a non-executive director. Burns has also …
Digital Pharma: Merck Serono expands PKU website
March 16, 2010Medical Communications Kuvan, Merck Serono, PKU
Merck Serono has expanded its European phenylketonuria disease awareness website, adding versions in French and Spanish. The website was originally …
Lilly acquires rights to testosterone treatment
March 16, 2010Sales and Marketing Acrux, hormone, lilly, male health
Lilly have entered into a worldwide licensing agreement with Australian-based Acrux for Axiron, an experimental under-arm testosterone applicator.The treatment is …
OSI resists Astellas and invites other offers
March 16, 2010Sales and Marketing Astellas, OSI, merger
A new takeover bid launched by Japanese pharma company Astellas for OSI Pharma has been rejected by the company’s board. …
Conventional hypertension prescribing ‘should be reconsidered’
March 16, 2010NICE, hypertension
New findings throwing doubt on conventional wisdom about high blood pressure may have implications for NICE’s advice on hypertension. Published …
Edinburgh BioQuarter appoints commercialisation director
March 16, 2010Research and Development Edinburgh BioQuarter, appointment, research and development
Dr Michael Capaldi has joined Scottish life sciences research hub Edinburgh BioQuarter as director of commercialisation. He will lead a …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
